Animal Health Players Pursue Vertical Integration as a Path to Growth
Animal health businesses that have established a strong presence within their area of expertise, may be considering where the next best path to growth lies. While cross-border expansion and consolidation is one possible way forward, another option is to explore targets outside their core business and pursue a vertical integration strategy.
In 2020, the global animal health market was valued at $45.4 billion and is expected to grow at a 9% CAGR from 2021 to 2028. Within this global market, opportunities in pharmaceuticals, hospitals, feed, technology and more are ripe for investment as players consider the best vertical integration strategy.
Within the animal health sector, the pharmaceutical market is dominated by four large players: Zoetis, Merck, Boehringer Ingelheim and Elanco. Given the size of each of these companies, they face challenges when looking to grow by making acquisitions within their core segments due to antitrust laws. To continue growing without facing regulatory scrutiny, these companies are pursuing unique expansion strategies.
For example, Zoetis moved outside its core pharmaceutical business to acquire Abaxis, a diagnostic technology company. This acquisition allowed Zoetis to provide additional products and services to its veterinarian customers. Subsequently, Zoetis acquired a small, U.K.-based, vet-to-client communication platform, called Virtual Recall. This acquisition increased Zoetis’ access and connection to veterinarians via support services to clinics, enhancing compliance, education and engagement by the pet owner with their clinic, as well as the Zoetis brand among veterinarians.
Distributors are in a similar position. Covetrus, MWI Animal Health and Patterson, who dominate the distribution space, will also need to explore outside their sector to continue their growth. Earlier in 2021, Lincoln International worked as the financial advisor for Covetrus as it worked to acquire VCP, a market leading platform in veterinary wellness plan administration. With this acquisition, Covetrus can now provide its clients with unique wellness plans to meet the needs of each animal and pet parent.
Beyond the pharmaceutical and distribution subsectors, veterinary hospitals can also benefit from exploring vertical integration strategies. Presently, the activity in the sector parallels the consolidation that occurred in the human healthcare industry in the 1990s. This activity has piqued the interest of private equity firms, who have poured capital into veterinary hospital chains in recent years.
However, private equity investors are presented with challenges in maintaining profitability within animal hospital platforms, including:
In the U.S. and U.K. veterinarian hospitals are understaffed. From the demand for after hours care to the rising numbers of companion animals adopted during the pandemic, there are simply too many pets and not enough veterinarians. In the U.K., the number of new veterinarians registering to work is down to as few as 20 per month, a significant decrease from the 80 to 100 per month registering in years past. Across the globe, approximately half of veterinarian technicians burn out of the profession within their first five years.
As more private equity buyers show interest in acquiring veterinary hospital chains, competition for assets is at an all-time high. Given the number of interested buyers in the market, valuations are expected to continue increasing.
Efficiency and technology
COVID-19 accelerated the already emerging trend of the industry embracing technological innovation. Ideally, this integration of technology will increase efficiency within clinics and better meet the needs of both pet parents and clinicians. Virtual consultations were the only option for pet parents, outside of emergencies, in the U.K. and several European countries during the pandemic. If hospitals don’t embrace such technology they will lose market share.
Lincoln International's healthcare experts explore the animal health and veterinary market.
- Click here to download a printable version of this perspective.
- Sign up to receive Lincoln's perspectives
|Spotlight on the Indian Market
In India, the animal healthcare market is largely focused on the production and consumption of animals within the agricultural sector. Unlike North America and Europe, large animal health players have yet to emerge in the Indian market. As the number of companion animals in the country grows, Lincoln expects to see more clinic and hospital players appear, followed by consolidation by private equity and corporate buyers. Leading corporations, such as Mars and Nestle, are already present in India in the pet food market. However, other players in the space are left to wonder: how long will it be before these leading companies move into the clinics space? An early entrant in the space, Heads Up For Tails, started as a pet retail platform and is rapidly moving into the clinics space, getting a head start over their competitors as activity in the market takes off. To support its ambitions, the business recently raised growth capital from blue-chip investors Verlinvest and Sequoia Capital India.
Acquiring targets outside its core business can be key to scaling an animal health company. For both private equity and strategic investors interested in this market, items to consider related to vertical integration include:
Technology provides veterinarian hospitals the opportunity to streamline operations and offer a broader range of services, elevating client and employee experiences as well increasing profitability. Veterinarian hospitals and their private equity owners are increasingly implementing technology solutions. Technology integration is quickly becoming table stakes. Small Door, a technology-enabled, veterinary clinic, in New York, New York, recently raised $20 million in financing to open new locations in the coming years. Looking at virtual consultation developments, corporate veterinarian service providers have pursued deals, such as Europe’s IVC Evidencia acquiring PawSquad and Lincoln selling the Vet Connection to Pets At Home Plc. In both deals the buyers sought to acquire a key value enhancer for clinics and service offering for pet parents, while providing flexibility to working veterinarian practices leveraging such platforms.
The shortage of veterinarians remains a pressing issue for the animal health industry. To combat this challenge, an acquisition of a staffing agency could help streamline the matching of available veterinarians to hospitals in need and preemptively predict when hospitals will require additional staff.
Foster Innovation and Establish a Robust Research and Development Pipeline
Large pharmaceutical players in animal health are increasingly focused on acquiring platforms to help drive innovation and expand their research and development (R&D) pipelines. For example, Elanco’s acquisitions of Kindred Biosciences and Aratana Therapeutics are recent instances of a large pharmaceutical player expanding its R&D capabilities through targeted acquisitions.
Meet Professionals with Complementary Expertise
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | European Co-head HealthcareFrankfurt
What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access
The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More
Scrip Asks…What Does 2024 Hold for Biopharma?
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
Lincoln International advised Mars on the sale of Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised Seven Hills Capital on raising capital for Reliable Medical